Duke Robotics (DUKR) director awarded 16K stock options

Rhea-AI Filing Summary

DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Nachtomy Erez

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Option to Purchase Common Stock	16,000	$0.00	--

Holdings After Transaction: Option to Purchase Common Stock — 16,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nachtomy Erez

(Last) (First) (Middle)

C/O DUKE ROBOTICS CORP.

10 HARIMON STREET

(Street)

MEVO CARMEL SCIENCE & IND PARK L3 2069203

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DUKE Robotics Corp. [ DUKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$7.88	03/10/2026		A		16,000(1)		(1)	03/10/2032	Common Stock	16,000	$0	16,000	D

Explanation of Responses:

1. The option vests in three equal annual installments beginning on March 10, 2027.

	/s/ Erez Nachtomy	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DUKE Robotics (DUKR) report for Nachtomy Erez?

DUKE Robotics reported an option grant to director Nachtomy Erez for 16,000 shares of common stock. The options were awarded at a $7.88 exercise price, vest in three equal annual installments starting March 10, 2027, and expire on March 10, 2032 as long-term equity compensation.

How many DUKE Robotics (DUKR) shares are covered by the new option grant?

The new option grant to director Nachtomy Erez covers 16,000 shares of DUKE Robotics common stock. These options are structured as a long-term incentive, vesting in three equal annual tranches beginning March 10, 2027, and give Erez the right to buy shares at $7.88 before March 10, 2032.

What is the exercise price and term of Nachtomy Erez’s DUKE Robotics options?

The options granted to Nachtomy Erez have an exercise price of $7.88 per DUKE Robotics share. They expire on March 10, 2032, providing a multi-year window to purchase stock once vested, with vesting occurring in three equal annual installments beginning March 10, 2027, subject to continued service.

How do Nachtomy Erez’s DUKE Robotics (DUKR) options vest over time?

The 16,000-share option grant to Nachtomy Erez vests in three equal annual installments. Vesting begins on March 10, 2027, meaning roughly one-third of the options become exercisable each year over three years, aligning director incentives with longer-term company performance and service duration.

Did the DUKE Robotics (DUKR) director buy or sell shares in this filing?

The director did not buy or sell shares on the open market in this filing. Instead, Nachtomy Erez received a compensation-related grant of options for 16,000 shares, exercisable at $7.88, with vesting in three annual installments starting March 10, 2027, and expiration on March 10, 2032.